Young Jun Kang
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- NF-κB Signaling Pathways
- Immunology top 5%
- Immune Response and Inflammation
- Immune Cell Function and Interaction
Papers in
-
- Melanoma and MAPK Pathways 8
- Circular RNAs in diseases 4
- RNA modifications and cancer 4
-
- NF-κB Signaling Pathways 9
- MicroRNA in disease regulation 9
- Cancer-related molecular mechanisms research 6
- Co-authors
- Motoyuki Otsuka (16 shared papers)Jiahuai Han (15 shared papers)Masao Omata (4 shared papers)Takahiro Kishikawa (6 shared papers)Takeshi Yoshikawa (6 shared papers)Akemi Takata (6 shared papers)Kazuhiko Koike (6 shared papers)Haruhiko Yoshida (5 shared papers)
- Journals
- The Journal of Immunology (5 papers)Journal of Biological Chemistry (4 papers)Nature Communications (3 papers)Scientific Reports (2 papers)Immunity (2 papers)
- Partner nations
- United StatesJapanSouth Korea
In The Last Decade
Young Jun Kang
50 papers receiving 3.7k citations
Young Jun Kang's Hit Papers
Peers
Comparison fields: 5 of 169
- Cancer Research 768
- Immunology 746
- Molecular Biology 1.8k
- Oncology 450
- Cell Biology 180
Countries citing papers authored by Young Jun Kang
This map shows the geographic impact of Young Jun Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Young Jun Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Young Jun Kang more than expected).
Fields of papers citing papers by Young Jun Kang
This network shows the impact of papers produced by Young Jun Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Young Jun Kang. The network helps show where Young Jun Kang may publish in the future.
Co-authors
The 25 scholars most cited alongside Young Jun Kang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Correction: Corrigendum: MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma Hit paper breakdown → | 2012 | 1166 |
| 2 | 2007 | 293 | |
| 3 | 2007 | 225 | |
| 4 | 2008 | 213 | |
| 5 | 2008 | 131 | |
| 6 | 2010 | 126 | |
| 7 | 2015 | 120 | |
| 8 | 2014 | 98 | |
| 9 | 2011 | 97 | |
| 10 | 2010 | 92 | |
| 11 | 2007 | 92 | |
| 12 | 1996 | 91 | |
| 13 | 2010 | 89 | |
| 14 | 2012 | 85 | |
| 15 | 1995 | 85 | |
| 16 | 2007 | 83 | |
| 17 | 2006 | 75 | |
| 18 | 2013 | 72 | |
| 19 | 2005 | 69 | |
| 20 | 2006 | 45 |
About Young Jun Kang
Young Jun Kang is a scholar working on Molecular Biology, Cancer Research, Immunology, Epidemiology and Oncology, having authored 50 papers that have together received 3.8k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (9 papers), MicroRNA in disease regulation (9 papers), Melanoma and MAPK Pathways (8 papers), Immune Response and Inflammation (8 papers), Cancer-related molecular mechanisms research (6 papers), Immune cells in cancer (5 papers), Circular RNAs in diseases (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (768 citations), Immunology (746 citations), Molecular Biology (1.8k citations), Oncology (450 citations) and Cell Biology (180 citations). Young Jun Kang has collaborated with scholars based in United States, Japan and South Korea. Frequent co-authors include Motoyuki Otsuka, Jiahuai Han, Masao Omata, Takahiro Kishikawa, Takeshi Yoshikawa, Akemi Takata, Kazuhiko Koike, Haruhiko Yoshida, Masao Akanuma and Kentaro Kojima. Their work appears in journals such as The Journal of Immunology, Journal of Biological Chemistry, Nature Communications, Scientific Reports and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.